Company Filing History:
Years Active: 2009
Title: The Innovations of Chunhao Zhang
Introduction
Chunhao Zhang, based in LaSalle, CA, is a prominent inventor known for her contributions to the field of pharmaceutical chemistry. With a unique focus on developing scalable processes for complex compounds, she has achieved significant recognition within the industry, culminating in two valuable patents.
Latest Patents
Chunhao Zhang's latest patents include an innovative approach to the synthesis of rapamycin derivatives. The first patent, titled "Scalable process for the preparation of a rapamycin 42-ester from a rapamycin 42-ester boronate," outlines a method for reacting a rapamycin 42-ester boronate with a diol to produce a purified form of rapamycin 42-ester through recrystallization. Additionally, this patent presents an efficient method for isolating and purifying rapamycin 42-ester boronate from residual contaminants, improving commercial viability.
The second patent, "Process for the preparation of purified crystalline CCI-779," focuses on the creation of purified crystalline CCI-779, a compound that holds therapeutic potential. This innovation not only enhances the quality of the product but also streamlines the manufacturing process, allowing for more effective production.
Career Highlights
Chunhao Zhang is currently employed at Wyeth, where she applies her expertise in pharmaceutical processes to advance product development. Her contributions are instrumental in bridging the gap between laboratory research and real-world applications. With two patents to her name, she is recognized as a key player in her organization.
Collaborations
Throughout her career, Chunhao has collaborated with esteemed colleagues, including Clifford William Coughlin and Adam P Michaud. These partnerships have fostered a dynamic environment for innovation, allowing her to enhance her research outputs and contribute to various collaborative achievements within Wyeth.
Conclusion
Chunhao Zhang stands out as a dedicated inventor whose work is making significant strides in pharmaceutical science. Her recent patents not only highlight her innovative spirit but also the importance of collaboration in advancing the field. As she continues her work at Wyeth, her contributions are set to impact the industry and improve therapeutic options for patients.